Journal of Pain and Symptom Management
Volume 39, Issue 4 , Pages 702-711 , April 2010

Errors in Opioid Prescribing: A Prospective Survey in Cancer Pain

This work was presented at the American Society of Clinical Oncology Annual Meeting, New Orleans, LA, June 10–13, 2004.

,Accepted 28 September 2009.

References 

  1. Ripamonti C, Zecca E, De Conno F. Pharmacological treatment of cancer pain: alternative routes of opioid administration. Tumori. 1998;84:289–300
  2. Davis M, Walsh D. Cancer pain syndromes. Eur J Palliat Care. 2000;7:206–209
  3. Smith HS. Variations in opiod responsiveness. Pain Physician. 2008;11:237–248
  4. Davis MP, Walsh D. Epidemiology of cancer pain and factors influencing poor pain control. Am J Hosp Palliat Care. 2004;21:137–142
  5. Ventafridda V, Tamburini M, Caraceni A, De Conno F, Naldi F. A validation study of the WHO method for cancer pain relief. Cancer. 1987;59:850–856
  6. Grond S, Zech D, Schug SA, Lynch J, Lehmann KA. Validation of World Health Organization guidelines for cancer pain relief during the last days and hours of life. J Pain Symptom Manage. 1991;6:411–422
  7. Walker VA, Hoskin PJ, Hanks GW, White ID. Evaluation of WHO analgesic guidelines for cancer pain in a hospital-based palliative care unit. J Pain Symptom Manage. 1988;3:145–149
  8. Kochhar R, LeGrand SB, Walsh D, et al. Opioids in cancer pain: common dosing errors. Oncology (Williston Park). 2003;17:571–575
  9. Walsh D, Rivera N, Davis MP, Lagman R, LeGrand SB. Strategies for pain management: Cleveland clinic foundation guidelines for opioid dosing for cancer pain. Support Cancer Ther. 2004;1:157–164
  10. Strack PL, Sherwood GD, Adams-McNeill J, Thomas EJ. Identifying and addressing medical errors in pain mismanagement. Jt Comm J Qual Improv. 2001;27:191–199
  11. Mercadante S. Predictive factors and opioid responsiveness in cancer pain. Eur J Cancer. 1998;34:627–631
  12. Von Roenn JH, Cleeland CS, Gonin R, Hatfield AK, Pandya KJ. Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med. 1993;119:121–126
  13. Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994;330:592–596
  14. Estfan B, Davis MP, Walsh D, et al. The business of palliative medicine—part 5: service utilization in a comprehensive integrated program. Am J Hosp Palliat Med. 2007;24:211–218
  15. Sandblom G, Carlsson P, Sennfält K, Varenhorst E. A population-based study of pain and quality of life during the year before death in men with prostate cancer. Br J Cancer. 2004;90:1163–1168
  16. Coyle N. In their own words: seven advanced cancer patients describe their experience with pain and the use of opioid drugs. J Pain Symptom Manage. 2004;27:300–309
  17. Ressel GW. NIH releases statement on managing pain, depression, and fatigue in cancer. Am Fam Physician. 2003;67:423–424
  18. Hanks GW, Cono F, Cherny N, et al. Expert Working Group of the Research Network of the European Association for Palliative Care Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer. 2001;84:587–593
  19. Krakowski I, Theobald S, Balp L, et al. FNCLCC Summary version of the standards, opinions and recommendations for the use of analgesia for the treatment of nociceptive pain in adults with cancer (update 2002). Br J Cancer. 2003;89(Suppl 1):S67–S72
  20. Benedetti C, Brock C, Cleeland C, et al. National Comprehensive Cancer Network NCCN practice guidelines for cancer pain. Oncology (Williston Park). 2000;4:135–150
  21. Pargeon KL, Hailey BJ. Barriers to effective cancer pain management: a review of the literature. J Pain Symptom Manage. 1999;18:358–368
  22. Walsh D, Donnelly S, Rybicki L. The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer. 2000;8:175–179
  23. Cherny NJ, Chang V, Frager G, et al. Opioid pharmacotherapy in the management of cancer pain: a survey of strategies used by pain physicians for the selection of analgesic drugs and route of administration. Cancer. 1995;76:1283–1293
  24. Mercadante S, Maddaloni S, Roccella S, Salvaggio L. Predictive factors in advanced cancer pain treated only by analgesics. Pain. 1992;50:151–155
  25. Sanchez Gonzalez R, Ruperez Cordero O, Guerra Merino A, et al. Evaluation of primary care treatment of oncology patients with opiates. Aten Primaria. 1995;16:92–95
  26. Herndon CM, Kalauokalani DA, Cunningham AJ, Jackson KC, Dunteman ED. Anticipating and treating opioid-associated adverse effects. Expert Opin Drug Saf. 2003;2:305–319
  27. Hanks GW, Forbes K. Opioid responsiveness. Acta Anaesthesiol Scand. 1997;41:154–158

PII: S0885-3924(10)00082-5

doi: 10.1016/j.jpainsymman.2009.09.009

Journal of Pain and Symptom Management
Volume 39, Issue 4 , Pages 702-711 , April 2010

Article Tools

* Image Usage & Resolution